Background illustration for clinical trials search

Lung Cancer Clinical Trials

Browse 2,144 lung cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer

for
Locally Advanced Lung Non-Small Cell Carcinoma,
Location: Columbus OH, Duarte CA
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05136846

Phase 1, Recruiting

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

for
Advanced Lung Non-Small Cell Carcinoma,
Location: Brewer ME, South Weymouth MA, Boston MA, Brighton MA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 70+

Code: NCT06096844

Phase 3, Recruiting

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

for
Advanced Lung Non-Squamous Non-Small Cell Carcinoma,
Location: Worcester MA, Waterford CT, Guilford CT, Hartford CT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04181060

Phase 3, Recruiting
New

Implantable Microdevices for in Situ Evaluation of Drug Responses in Lung Cancer

for
Lung Cancer, Mesothelioma, Suspected Lung Cancer,
Location: Boston MA
Sponsor: Oliver Jonas

Sex: All

Age: 18+

Code: NCT07892300

Early Phase 1, Recruiting
New

Dissemination Of Lung Cancer Screening Education Through Tobacco Quitlines

for
Lung Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07720141

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib

for
Lung Cancer
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT07782359

Phase 1, Recruiting
New

Lungs on Fire: Wildfire Smoke, Incident Diseases, Susceptible Populations, and Community Values in Canada

for
Asthma, Chronic Obstructive Pulmonary Disease (COPD),
Location: Vancouver
Sponsor: University of British Columbia

Sex: All

Age: 19 - 70+

Code: NCT07536178

Recruiting

Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients From a Safety-Net Healthcare System

for
Lung Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 50 - 70+

Code: NCT07382557

Recruiting

Health Education Approach to Lung Screening

for
Lung Cancer
Location: Richmond VA, Carrboro NC, Charleston SC
Sponsor: Virginia Commonwealth University

Sex: All

Age: 50 - 70+

Code: NCT06070870

Recruiting

MIRA Clinical Learning Environment (MIRACLE): Lung

for
Lung Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT05689437

Recruiting

Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer

for
Lung Neoplasm
Location: San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All

Age: 18+

Code: NCT03655015

Recruiting

Avecure Flexible Microwave Ablation Probe For Lung Nodules

for
Stage I - II Primary Lung Cancer, Stage I Lung Cancer,
Location: Boston MA
Sponsor: Beth Israel Deaconess Medical Center

Sex: All

Age: 22+

Code: NCT05281237

Recruiting

The Rise in Robotic Atypical Segmentectomies

for
Lung Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT04644952

Recruiting

Use of Harmonic Scalpel to Decrease Lymphatic and Chest Tube Drainage After Lymph Node Dissection With Lobectomy.

for
Lung Cancer
Location: Norfolk VA
Sponsor: Sentara Cardiovascular Research Institute

Sex: All

Age: 20 - 70+

Code: NCT00591552

Recruiting

Non-ablative Oligofractionated Radiation Therapy Before Surgical Transplantation As Radiovaccination

for
Transplant-Related Lung Cancer
Location: Toronto
Sponsor: Marc de Perrot

Sex: All

Age: 18+

Code: NCT04782752

Recruiting

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

for
Lung Cancer, Breast Cancer
Location: Hackensack NJ, Montreal, Ottawa, Miami FL, Cleveland OH,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06618287

Phase 1, Phase 2, Recruiting

Centralized Screening Unit (CSU) at Montefiore-Einstein

for
Lung Cancer
Location: The Bronx NY
Sponsor: Albert Einstein College of Medicine

Sex: All

Age: 50 - 70+

Code: NCT06284408

Recruiting

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

for
Head and Neck Cancer, Lung Cancer, Lip Cancer, Lip Neoplasms,
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT00568490

Recruiting

Post SBRT Pulmonary Metastasectomy (PSPM) Trial

for
Surgical Resection, Stereotactic Body Radiotherapy, Lung Cancer,
Location: Hamilton
Sponsor: McMaster University

Sex: All

Age: 18+

Code: NCT04160143

Recruiting

Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies

for
Head and Neck Cancer, Lung Cancer, Gastrointestinal Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18+

Code: NCT05995821

Recruiting

What is lung cancer?

Lung cancer starts when cells in the airways or lungs grow out of control. About 229,000 Americans will be diagnosed in 2026. There are two main types: non small cell lung cancer, about 85 percent of cases, and small cell lung cancer, which grows and spreads faster and is treated differently. Smoking causes most cases, but 10 to 20 percent happen in people who never smoked, from causes like radon, air pollution, or genetic changes. Most people are diagnosed around age 70.

Two things changed treatment. First, many lung cancers are driven by a single gene change, and pills that target that specific change can control the cancer for years, so tumors are now routinely tested for these changes before treatment starts. Second, immunotherapy works especially well in lung cancer, and some people with advanced disease are alive and well more than five years later. New targeted drugs kept getting approved through 2025, which is why lung cancer has more recruiting trials than any cancer except breast cancer.

Types of lung cancer clinical trials

Who can participate in lung cancer clinical trials?

What causes lung cancer?

Does vaping cause lung cancer?

The stages of lung cancer, and why they matter for trials

How to enroll in a lung cancer clinical trial